p53 and PTEN regulate TAGLN to inhibit bladder cancer cell proliferation.[12] As a result, we now broaden the molecular interactome with TAGLN to add HDAC2 regulating p53 deacetylation at K382, in turn, mediating acceleration of cell cycle progression. Here, TP53 is linked to urinary bladder cancer.